Brief: Alzinova Gets Fast Track Designation from US FDA
Oct 6 (Reuters) - Alzinova AB ALZ.ST: SAID ON SATURDAY THAT U.S. FDA HAS GRANTED FAST TRACK DESIGNATION FOR CO’S VACCINE CANDIDATE ALZ-101 IN ALZHEIMER’S DISEASE Source text for Workspace: nMFN7Yr2QN Further company coverage: ALZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))